Campbell Shannon has filed 6 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 30550 shares of Black Diamond Therapeutics, Inc. ($BDTX) on June 12, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 12, 2025 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 55,028,371 | 9999.99% | 0.06% |
| Dec. 13, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Common Stock | 4500 | $2.50 | 8,865.0000 | 56,507,956 | 103.09% | 0.01% |
| Sept. 20, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Common Stock | 2354 | $4.78 | 4,365.0000 | 43,954,649 | 117.06% | 0.01% |
| June 21, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Common Stock | 2011 | $4.98 | 2,011.0000 | 43,954,649 | 9999.99% | 0.00% |
| June 6, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 30550 | $0.00 | 30,550.0000 | 43,954,649 | 9999.99% | 0.07% |
| April 10, 2024 | Black Diamond Therapeutics, Inc. | $BDTX | Campbell Shannon | Not found | A | Stock Option (Right to Buy) | 61100 | $0.00 | 61,100.0000 | 43,954,649 | 9999.99% | 0.14% |